Latest Articles
Pelvic pain clinic for Wyoming - Central Coast News
Pelvic pain clinic for Wyoming Central Coast News
Published: Nov. 14, 2025, 7:26 a.m.
'I FaceTimed best friend to tell her I was pregnant and her response left me gobsmacked' - The Mirror
'I FaceTimed best friend to tell her I was pregnant and her response left me gobsmacked' The Mirror
Published: Nov. 14, 2025, 7:12 a.m.
Patient Perspective: Fatphobia Hinders Effective Health Care - Infectious Disease Advisor
Patient Perspective: Fatphobia Hinders Effective Health Care Infectious Disease Advisor
Published: Nov. 14, 2025, 5 a.m.
‘No longer an afterthought’: Major health win for women with chronic pain - goldcoastbulletin.com.au
‘No longer an afterthought’: Major health win for women with chronic pain goldcoastbulletin.com.au
Published: Nov. 14, 2025, 3:15 a.m.
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative
Published: Nov. 13, 2025, 9:25 p.m.
‘A whole-body disease’: Why endometriosis is so difficult to diagnose and treat - YaleNews
‘A whole-body disease’: Why endometriosis is so difficult to diagnose and treat YaleNews
Published: Nov. 13, 2025, 8:01 p.m.
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal
Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal
Published: Nov. 13, 2025, 1:03 p.m.
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech
Published: Nov. 13, 2025, 9 a.m.
What it’s like living in chronic pain as a woman - bodyandsoul.com.au
What it’s like living in chronic pain as a woman bodyandsoul.com.au
Published: Nov. 13, 2025, 7:18 a.m.
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare
Published: Nov. 13, 2025, 6:17 a.m.
Link copied to clipboard!